Therapeutic use of transdermal naloxone (naloxone TTS)

摘要

Use of a transdermal therapeutic system consisting of a carrier layer, a matrix containing naloxone as active ingredient, and an optional removable layer, is claimed for opiate intoxication treatment, by in-patients or out-patients, and/or treatment of obstipation. Preferably naloxone may be used as the free base or as a salt, e.g. the hydrochloride. The matrix is self-adhesive.